Early Detection of Prostate Cancer in Primary Care
Join this webinar with Dr Alexander Norman and Amy Rylance to explore prostate cancer risk factors, PSA blood testing, diagnostic updates, health inequalities and understand the development of the National Screening Committee (NSC) and the TRANSFORM trial. Chaired by Rhiannon Ashman and in collaboration with MIMs, the session will provide practical guidance to support informed decision-making and improve outcomes in primary care.
RCGP Men’s Health June 2025 Prostate Cancer UK Sponsored Symposium | Latest Updates in Prostate Cancer for GPs
Join this webinar with Dr Sam Merriel to explore prostate cancer risk factors, PSA blood testing, diagnostic updates, and health inequalities. Chaired by Dr Anand Patel, the session will provide practical guidance to support informed decision-making and improve outcomes in primary care. *This webinar recording will be available until April 2026*
Early Diagnosis Webinar for Scotland
Join Dr Sam Merriel, GP and NIHR Academic Clinical Lecturer at the Centre for Primary Care and Health Services Research at the University of Manchester, and Naomi Line, Education Manager at Prostate Cancer UK for a focused webinar on enhancing early detection of prostate cancer in Scotland. Tailored for primary care professionals, this session offers insights into risk assessment, PSA testing, and addressing health disparities.
PSA diagnostic case studies
Dr Sam Merriel and Dr Olly Hulson cover some case studies common to Primary Care, to explore early diagnosis and diagnostic pathways through real-world scenarios.
Using real world data to bridge the evidence gap left by prostate cancer screening trials
How Real-World Data can demonstrate reduction in harms of prostate cancer screening and inform the future of diagnostics to improve early diagnosis.
The modern prostate cancer diagnostic pathway
Dr. Olly Hulson provides an overview of the modern prostate cancer diagnostic pathway.
PSA consensus recommendations and implications for practice
Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Lived experience conversation
Meg Burgess, Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus
The report examines the optimal use of the PSA test for detecting prostate cancer in asymptomatic UK men, recommends proactive testing for those at higher risk, and suggests reviewing existing guidelines to improve screening practices.